Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127440021 | 12744002 | 1 | I | 20160701 | 20160907 | 20160914 | 20160914 | EXP | GB-MHRA-EYC 00144634 | PHHY2016GB123916 | SANDOZ | 87.00 | YR | F | Y | 0.00000 | 20160914 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127440021 | 12744002 | 1 | PS | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | Oral | 10 MG QD | N | U | 200889 | 10 | MG | QD | |||||
127440021 | 12744002 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | REDUCING REGIME STARTED BY DERMATOLOGIST 25MG REDUCING BY 5MG EVERY 3 DAYS TO ZERO. | U | 0 | |||||||||
127440021 | 12744002 | 3 | C | BECLOMETHASONE DIPROPIONATE | BECLOMETHASONE DIPROPIONATE | 1 | Nasal | U | 0 | ||||||||||
127440021 | 12744002 | 4 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
127440021 | 12744002 | 5 | C | CETRABEN EMOLLIENT | 2 | Unknown | U | 0 | CREAM | ||||||||||
127440021 | 12744002 | 6 | C | COCODAMOL | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | 15/500MG AS NEEDED. | U | 0 | |||||||||
127440021 | 12744002 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | U | 0 | ||||||||||
127440021 | 12744002 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | U | 0 | ||||||||||
127440021 | 12744002 | 9 | C | ASACOL | MESALAMINE | 1 | Unknown | U | 0 | ||||||||||
127440021 | 12744002 | 10 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
127440021 | 12744002 | 11 | C | SALBUTAMOL | ALBUTEROL | 1 | Respiratory (inhalation) | U | 0 | INHALER |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127440021 | 12744002 | 1 | Asthma |
127440021 | 12744002 | 2 | Product used for unknown indication |
127440021 | 12744002 | 3 | Product used for unknown indication |
127440021 | 12744002 | 4 | Product used for unknown indication |
127440021 | 12744002 | 5 | Product used for unknown indication |
127440021 | 12744002 | 6 | Product used for unknown indication |
127440021 | 12744002 | 7 | Product used for unknown indication |
127440021 | 12744002 | 8 | Product used for unknown indication |
127440021 | 12744002 | 9 | Product used for unknown indication |
127440021 | 12744002 | 10 | Product used for unknown indication |
127440021 | 12744002 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127440021 | 12744002 | DE |
127440021 | 12744002 | LT |
127440021 | 12744002 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127440021 | 12744002 | Dyspnoea | |
127440021 | 12744002 | Eosinophilic granulomatosis with polyangiitis | |
127440021 | 12744002 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127440021 | 12744002 | 1 | 201601 | 0 | ||
127440021 | 12744002 | 2 | 201606 | 0 |